Publications - William A . Faubion, M.D.

Back to Research Profile

1. Afif W, Leighton JA, Hanauer SB, Loftus EV Jr, Faubion WA, Pardi DS, Tremaine WJ, Kane SV, Bruining DH, Cohen RD, Rubin DT, Hanson KA, Sandborn WJ. Open-label study of adalimumab in patients with ulcerative colitis including those with prior loss of response or intolerance to infliximab. Inflamm Bowel Dis 2009 Sep; 15(9):1302-7.
   View PubMed
2. Afif W, Leighton JA, Hanauer SB, Loftus EV, Faubion WA, Pardi DS, Tremaine WJ, Kane SV, Bruining DH, Cohen RD, Rubin DT, Hanson KA, Sandborn WJ. Open-label study of adalimumab in patients with ulcerative colitis including those with prior loss of response or intolerance to infliximab. Inflamm Bowel Dis 2009 Sep; 15(9):1302-7.
   View PubMed
3. Kleinschek MA, Boniface K, Sadekova S, Grein J, Murphy EE, Turner SP, Raskin L, Desai B, Faubion WA, Malefyt RD, Pierce RH, McClanahan T, Kastelein RA. Circulating and gut-resident human Th17 cells express CD161 and promote intestinal inflammation. J Exp Med 2009 Mar 16; 206(3):525-34.
   View PubMed
4. Solem CA, Loftus EV Jr, Fletcher JG, Baron TH, Gostout CJ, Petersen BT, Tremaine WJ, Egan LJ, Faubion WA, Schroeder KW, Pardi DS, Hanson KA, Jewell DA, Barlow JM, Fidler JL, Huprich JE, Johnson CD, Harmsen WS, Zinsmeister AR, Sandborn WJ. Small-bowel imaging in Crohn's disease: a prospective, blinded, 4-way comparison trial. Gastrointest Endosc 2008 Aug; 68(2):255-66. Epub 2008 Jun 02.
   View PubMed
5. Bell MP, Svingen PA, Rahman MK, Xiong Y, Faubion WA Jr. FOXP3 regulates TLR10 expression in human T regulatory cells. J Immunol 2007 Aug 1; 179(3):1893-900.
   View PubMed
6. Radhakrishnan S, Wiehagen KR, Pulko V, Van Keulen V, Faubion WA, Knutson KL, Pease LR. Induction of a Th1 response from Th2-polarized T cells by activated dendritic cells: dependence on TCR:peptide-MHC interaction, ICAM-1, IL-12, and IFN-gamma. J Immunol 2007 Mar 15; 178(6):3583-92.
   View PubMed
7. Desai D, Faubion WA, Sandborn WJ. Review article: biological activity markers in inflammatory bowel disease. Aliment Pharmacol Ther 2007 Feb 1; 25(3):247-55.
   View PubMed
8. Tung J, Loftus EV, Freese DK, EI-Youssef M, Zinsmeister AR, Melton LJ, Harmsen WS, Sandborn WJ, Faubion WA. A population-based study of the frequency of corticosteroid resistance and dependence in pediatric patients with Crohn's disease and ulcerative colitis. Inflamm Bowel Dis 2006 Dec; 12(12):1093-100.
9. Tung J, Loftus EV Jr, Freese DK, El-Youssef M, Zinsmeister AR, Melton LJ 3rd, Harmsen WS, Sandborn WJ, Faubion WA Jr. A population-based study of the frequency of corticosteroid resistance and dependence in pediatric patients with Crohn's disease and ulcerative colitis. Inflamm Bowel Dis 2006 Dec; 12(12):1093-100.
   View PubMed
10. Faubion WA Jr, Bousvaros A. Medical therapy for refractory pediatric Crohn's disease. Clin Gastroenterol Hepatol 2006 Oct; 4(10):1199-213. Epub 2006 Jul 26.
    View PubMed
11. Bousvaros A, Sylvester F, Kugathasan S, Szigethy E, Fiocchi C, Colletti R, Otley A, Amre D, Ferry G, Czinn SJ, Splawski JB, Oliva-Hemker M, Hyams JS, Faubion WA, Kirschner BS, Dubinsky MC. Challenges in pediatric inflammatory bowel disease. Inflamm Bowel Dis 2006 Sep; 12(9):885-913.
    View PubMed
12. Bousvaros A, Sylvester F, Kugathasan S, Szigethy E, Fiocchi C, Colletti R, Otley A, Amre D, Ferry G, Czinn SJ, Splawski JB, Oliva-Hemker M, Hyams JS, Faubion WA, Kirschner BS, Dubinsky MC, Challenges in Pediatric IBD Study Groups. Challenges in pediatric inflammatory bowel disease. Inflamm Bowel Dis 2006 Sep; 12(9):885-913.
    View PubMed
13. Graham DB, Bell MP, McCausland MM, Huntoon CJ, van Deursen J, Faubion WA, Crotty S, McKean DJ. Ly9 (CD229)-deficient mice exhibit T cell defects yet do not share several phenotypic characteristics associated with SLAM- and SAP-deficient mice. J Immunol 2006 Jan 1; 176(1):291-300.
    View PubMed
14. Faubion WA, Tung Jeanne. Inflammatory bowel disease: a practical approach, series #16, growth failure in pediatric inflammatory bowel disease: prevalence, risk factors and treatment. Practical Gastroenterology January 2006; XXX(1):14-29.
15. Chopra A, Pardi DS, Loftus EV Jr, Tremaine WJ, Egan LJ, Faubion WA, Hanson KA, Johnson TA, Sandborn WJ. Budesonide in the treatment of inflammatory bowel disease: the first year of experience in clinical practice. Inflamm Bowel Dis 2006 Jan; 12(1):29-32.
    View PubMed
16. Faubion WA, Tung J. Growth failure in pediatric inflammatory bowel disease: Prevalence, risk factors, and treatment. Pract Gastroenterol 2006; 30(1):14-21, 25-6, 29.
17. Toruner M, Harewood GC, Loftus EV, Sandborn WJ, Tremaine WJ, Faubion WA, Schroeder KW, Egan LJ. Endoscopic factors in the diagnosis of colorectal dysplasia in chronic inflammatory bowel disease. Inflamm Bowel Dis 2005 May; 11(5):428-34.
    View PubMed
18. Sandborn WJ, Faubion WA. Biologics in inflammatory bowel disease: how much progress have we made? Gut 2004 Sep; 53(9):1366-73.
    View PubMed
19. Ji Hong-bin, Liao G, Faubion WA, Abadia-Molina AC, Cozzo C, Laroux FS, Caton A, Terhorst C. Cutting edge: the natural ligand for glucocorticoid-induced TNF receptor-related protein abrogates regulatory T cell suppression. J Immunol 2004; 172:5823-5827.
    View PubMed
20. Wang N, Satoskar A, Faubion WA, Howie D, Okamoto S, Feske S, Gullo C, Clarke K, Sosa MR, Sharpe AH, Terhorst C. The cell surface receptor SLAM controls T cell and macrophage functions. J Exp Med 2004; 199(9):1255-1264.
    View PubMed
21. Faubion WA, Loftus EV, Sandborn WJ, Freese DK, Perrault J. Pediatric "PSC-IBD": A descriptive report of associated inflammatory bowel disease among pediatric patients with PSC. Journal of Pediatric Gastroenterology & Nutrition 2001 Sep; 33(3):296-300.
    View PubMed
22. Faubion WA Jr, Loftus EV Jr, Harmsen WS, Zinsmeister AR, Sandborn WJ. The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology 2001 Aug; 121(2):255-60.
    View PubMed
23. De Jong YP, Abadia-Molina AC, Satoskar AR, Clarke K, Rietdijk ST, Faubion WA, Mizoguchi E, Metz CN, Al Sahli M, ten Hove T, Keates AC, Lubetsky JB, Farrell RJ, Mitchetti P, van Deventer SJ, Lolis E, David JR, Bhan AK, Terhorst C. Development of chronic colitis is dependent on the cytokine MIF. Nature Immunology 2001; 2(11):1061-6.
    View PubMed
24. Sandborn WJ, Faubion WA. Clinical pharmacology of inflammatory bowel disease therapies. Curr Gastroenterol Rep 2000 Dec; 2(6):440-5.
    View PubMed
25. Faubion WA, Gores GJ. Death receptors in liver biology and pathobiology. Hepatology 1999 Jan; 29(1):1-4.
    View PubMed
26. Faubion WA, Guicciardi ME, Miyoshi H, Bronk SF, Roberts PJ, Svingen PA, Kaufmann SH, Gores GJ. Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas. J Clin Invest 1999 Jan; 103(1):137-45.
    View PubMed
27. Jones B, Roberts PJ, Faubion WA, Kominami E, Gores GJ. Cystatin A expression reduces bile salt-induced apoptosis in a rat hepatoma cell line. Am J Physiol Gastrointest Liver Physiol 1998 Oct; 275(4):G 723-G 730.
28. Faubion WA Jr, Perrault J, Burgart LJ, Zein NN, Clawson M, Freese DK. Treatment of eosinophilic esophagitis with inhaled corticosteroids. Journal of Pediatric Gastroenterology & Nutrition 1998 Jul; 27(1):90-3.
    View PubMed
29. Faubion WA Jr, Zein NN. Gastroesophageal reflux in infants and children. Mayo Clin Proc 1998 Feb; 73(2):166-73.
    View PubMed
30. Faubion WAJ, Zein NN. Reflux esophagitis in infants and children. [Spanish]. Practica Pediatrica 1998; 7(7):16-25.
31. Faubion WA Jr, Zein NN. Gastroesophageal reflux in infants and children. Mayo Clin Proc 1998; 27(1):90-3.
32. Faubion WA, Nader S. Spinal cord surgery and galactorrhea: a case report. American Journal of Obstetrics and Gynecology 1997; 177(2):465-6.
    View PubMed